Added to YB: 2026-02-24
Pitch date: 2026-02-22
INVA [bullish]
Innoviva, Inc.
-0.21%
current return
Author Info
FluentInQuality invests in high-quality businesses that generate steady and sustainable cashflows, proven track records, and the potential to act as a true compounding machines over the long run. Sign up for the newsletter.
Company Info
Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally.
Market Cap
$1.7B
Pitch Price
$23.46
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.67
P/E
15.34
EV/Sales
3.96
Sector
Pharmaceuticals
Category
growth
6 High-Quality Stocks With 20%+ ROIC Wall Street Ignores - Innoviva, Inc.
INVA: Healthcare capital allocator earning high-margin royalties from partnered respiratory products, reinvesting FCF into commercial-stage assets vs risky R&D. Diversified portfolio reduces binary biotech risk. Asset-light model + balance sheet strength enable countercyclical M&A when healthcare valuations compress.
Read full article (2 min)